Executive Employment AgreementInvention and Non-Disclosure Agreement • February 28th, 2023 • OneSpan Inc. • Services-computer integrated systems design • Massachusetts
This EMPLOYMENT AGREEMENT (this “Agreement”) is made effective as of June 13, 2022 (the “Effective Date”), by and between OneSpan North America, Inc. (the “Company”), and Lara Mataac (“you”).
Dr. Nezam Afdhal, M.D. Charlestown, MA 02129 Dear Nezam:Invention and Non-Disclosure Agreement • January 5th, 2016 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
On behalf of Spring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), I am pleased to offer you employment with the Company. The purpose of this letter is to summarize the terms of your employment with the Company, should you accept our offer:
Exhibit 10.11 December 23, 1998 Richard P. Shea 52 Margin St. Cohasset, MA 02025 tel: (781) 383-2384 Dear Rick: On behalf of VARIAGENICS, I am writing to formally extend to you an offer of employment in the position of Vice President, Finance. In...Invention and Non-Disclosure Agreement • March 29th, 2000 • Variagenics Inc • Massachusetts
INVENTION AND NON-DISCLOSURE AGREEMENTInvention and Non-Disclosure Agreement • September 26th, 2005 • Vistaprint LTD • Commercial printing • Massachusetts
This Agreement is made between VistaPrint USA, Incorporated, a Delaware corporation (hereinafter referred to collectively with its parent company, affiliates and subsidiaries as the “Company”), and Anne Drapeau (the “Employee”).
June 12, 2014Invention and Non-Disclosure Agreement • January 4th, 2016 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • Massachusetts
On behalf of Editas Medicine, Inc. (the “Company”), I am pleased to offer you employment with the Company. The purpose of this letter agreement (the Agreement”) is to set forth the terms of your employment with the Company, should you accept our offer.
Martin DriscollInvention and Non-Disclosure Agreement • December 11th, 2015 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Invention and Non-Disclosure AgreementInvention and Non-Disclosure Agreement • September 18th, 2020
This Invention and Non-Disclosure Agreement (this “Agreement”) made this [____] day of [_____________], 20[ ], is by and between [_____________], a Delaware corporation (the “Company”), and [____________] (the “Employee”).
FORM OF INVENTION AND NON-DISCLOSURE AGREEMENTInvention and Non-Disclosure Agreement • May 19th, 1999 • Streamline Com Inc • Services-business services, nec • Massachusetts
INVENTION AND NON-DISCLOSURE AGREEMENTInvention and Non-Disclosure Agreement • March 28th, 2002 • Udate Com Inc • Services-services, nec • Delaware
This Agreement effective as of May 23, 2000 is made between uDate.com, Inc., a Delaware corporation (hereinafter referred to collectively with its predecessors and its past, current and future subsidiary corporations as the “Company”), and Anthony Dunn (the “Employee”).
Cambridge, MA 02141 P 617-401-9000 F 617-494-0985Invention and Non-Disclosure Agreement • November 12th, 2019 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • Delaware
On behalf of Editas Medicine, Inc., a Delaware corporation (the “Company”), I am pleased to offer you employment with the Company. The purpose of this letter is to summarize the terms of your employment with the Company, should you accept our offer:
Effective as of February 23, 2009 Kenneth M. Bate Concord, MA 01742 Dear Ken:Invention and Non-Disclosure Agreement • February 26th, 2009 • Nitromed Inc • Pharmaceutical preparations
Effective immediately prior to the closing of the Merger (as such term is defined in that certain Agreement and Plan of Merger, dated as of January 27, 2009, by and among NitroMed, Inc. (“NitroMed”), NTMD Parent Acquisition Corp., NTMD Acquisition Corp., Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P., Deerfield Special Situations Fund, L.P. and Deerfield Special Situations Fund International Limited), unless you are earlier terminated for cause, you will be terminated without cause as NitroMed’s President, Chief Executive Officer and Interim Chief Financial Officer. This agreement (the “Agreement”) sets forth the terms pursuant to which you will be terminated without cause immediately prior to closing of such Merger; the time of such closing is referred to herein as the “Effective Time” and the date of such closing is referred to herein as the “Effective Date.”
INVENTION AND NON-DISCLOSURE AGREEMENTInvention and Non-Disclosure Agreement • March 28th, 2002 • Udate Com Inc • Services-services, nec • Delaware
This Agreement effective as of May 23, 2000 is made between uDate.com, Inc., a Delaware corporation (hereinafter referred to collectively with its predecessors and its past, current and future subsidiary corporations as the “Company”), and Melvyn Morris (the “Employee”).
